— Know what they know.
Not Investment Advice
Also trades as: HBP.TO (TSX) · $vol 0M

HBPCF OTC

Helix BioPharma Corp.
1W: -55.0% 1M: -55.0% 3M: -55.0% YTD: -55.5% 1Y: +28.3% 3Y: +6.2% 5Y: -75.2%
$0.77
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Strong Sell · Power 34 · $58.8M mcap · 54M float · 0.0016% daily turnover · Short 83% of daily vol

Balance Sheet Trends

Total Assets
$19M +1155.7% ▲
5Y CAGR: +30.7%
Total Liabilities
$3M +102.5% ▲
5Y CAGR: +10.7%
Shareholders Equity
$16M +17322.2% ▲
5Y CAGR: +45.3%
Cash & Investments
$65K -94.0% ▼
5Y CAGR: -56.7%
Total Debt
$333K +0.0% ▲
5Y CAGR: +15.9%
Net Debt
$269K +124.8% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$4M$3M$808K$1M$65K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$4M$3M$808K$1M$65K
Net Receivables$0$0$0$54K$120K
Inventory$0$164K$0$0$0
Other Current Assets$0$0$0$0$222K
Total Current Assets$4M$4M$996K$1M$407K
Property, Plant & Equip.$47K$35K$33K$33K$4K
Goodwill & Intangibles$0$0$0$1K$18M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0-$1K$0
Total Non-Current Assets$47K$35K$33K$33K$18M
Total Assets$4M$4M$1M$1M$19M
— Liabilities —
Accounts Payable$1M$599K$493K$855K$0
Short-Term Debt$2M$2M$0$0$333K
Deferred Revenue$0$345K$0$0$0
Other Current Liabilities$0-$1K$998K$0$3M
Total Current Liabilities$4M$3M$2M$2M$3M
Long-Term Debt$2M$0$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$2M$0-$1K$0$0
Total Liabilities$5M$3M$2M$2M$3M
— Equity —
Common Stock$140M$148M$152M$159M$178M
Retained Earnings-$189M-$195M-$201M-$211M-$215M
Accumulated OCI$20M$10M$4M$0$4M
Total Stockholders Equity-$1M$319K-$844K-$90K$16M
Total Liabilities & Equity$4M$4M$1M$1M$19M
— Key Metrics —
Total Debt$4M$2M$0$0$333K
Net Debt$47K-$784K-$808K-$1M$269K
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms